These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
105 related articles for article (PubMed ID: 25345981)
1. Targeted therapy in travelers' diarrhea: what is the role for the non-absorbable? Riddle MS; Connor BA; Tribble DR J Travel Med; 2014; 21(6):365-8. PubMed ID: 25345981 [No Abstract] [Full Text] [Related]
2. Targeting of rifamycin SV to the colon for treatment of travelers' diarrhea: a randomized, double-blind, placebo-controlled phase 3 study. DuPont HL; Petersen A; Zhao J; Mundt A; Jiang ZD; Miller S; Flores J; Shringarpure R; Moro L; Bagin RG; Ballard ED; Totoritis MC J Travel Med; 2014; 21(6):369-76. PubMed ID: 25345982 [TBL] [Abstract][Full Text] [Related]
3. Enteroaggregative Escherichia coli diarrhea in travelers: response to rifaximin therapy. Infante RM; Ericsson CD; Jiang ZD; Ke S; Steffen R; Riopel L; Sack DA; DuPont HL Clin Gastroenterol Hepatol; 2004 Feb; 2(2):135-8. PubMed ID: 15017618 [TBL] [Abstract][Full Text] [Related]
4. Current concepts in travelers' diarrhea: epidemiology, antimicrobial resistance and treatment. Okhuysen PC Curr Opin Infect Dis; 2005 Dec; 18(6):522-6. PubMed ID: 16258326 [TBL] [Abstract][Full Text] [Related]
6. Rifaximin treatment of pathogen-negative travelers' diarrhea. DuPont HL; Haake R; Taylor DN; Ericsson CD; Jiang ZD; Okhuysen PC; Steffen R J Travel Med; 2007; 14(1):16-9. PubMed ID: 17241249 [TBL] [Abstract][Full Text] [Related]
7. Rifaximin: a nonabsorbed antimicrobial as a new tool for treatment of travelers' diarrhea. Steffen R J Travel Med; 2001 Dec; 8(Suppl 2):S34-9. PubMed ID: 12186672 [No Abstract] [Full Text] [Related]
8. A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea. Taylor DN; Bourgeois AL; Ericsson CD; Steffen R; Jiang ZD; Halpern J; Haake R; Dupont HL Am J Trop Med Hyg; 2006 Jun; 74(6):1060-6. PubMed ID: 16760520 [TBL] [Abstract][Full Text] [Related]
15. Zaldaride maleate, an intestinal calmodulin inhibitor, in the therapy of travelers' diarrhea. DuPont HL; Ericsson CD; Mathewson JJ; Marani S; Knellwolf-Cousin AL; Martinez-Sandoval FG Gastroenterology; 1993 Mar; 104(3):709-15. PubMed ID: 8440431 [TBL] [Abstract][Full Text] [Related]
16. Rifaximin: a new approach to the treatment of travelers' diarrhea. Conclusion. Ericsson CD J Travel Med; 2001 Dec; 8(Suppl 2):S40. PubMed ID: 12186673 [No Abstract] [Full Text] [Related]
17. Rifaximin: a new approach to the treatment of travelers' diarrhea. Introduction. Ericsson CD J Travel Med; 2001 Dec; 8(Suppl 2):S25. PubMed ID: 12186669 [No Abstract] [Full Text] [Related]
18. How to hit the runs for fifty million travelers at risk. Gorbach SL Ann Intern Med; 2005 May; 142(10):861-2. PubMed ID: 15897537 [No Abstract] [Full Text] [Related]
19. Summaries for patients. Can a new antibiotic safely prevent travelers' diarrhea? Ann Intern Med; 2005 May; 142(10):I30. PubMed ID: 15897526 [No Abstract] [Full Text] [Related]
20. Rifaximin (Xifaxan) for travelers' diarrhea. Med Lett Drugs Ther; 2004 Sep; 46(1191):74-5. PubMed ID: 15365508 [No Abstract] [Full Text] [Related] [Next] [New Search]